OLE MAALOES VEH 3, COPENHAGEN, G7
Provides Update Following Pre-BLA Meeting with FDA
Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Investor Presentation
News, Securities Holder Rights or Indentures
News, Material Contracts
Submission of Matters to a Vote of Security Holders
News
Reports First Quarter 2025 Financial Results and Business Highlights
Q2
Q1
FY 2024
Q3
FY 2023 amended
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 424(b)(2)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
SEC Staff Correspondence